Resources

A chat with our very first angel investor about patients, doctors and injecting innovation into the healthcare sector

Ocrevus (ocrelizumab) was approved in the US by the FDA in March 2017 for the treatment of adults with relapsing or primary progressive forms of MS, based on three clinical trials.

For US patients and patients worldwide with ALS.

Amsterdam leads European cities as top tech destination and why it’s only natural that it is home to TheSocialMedwork.

As we await the arrival of edaravone to US pharmacies, patients can access edaravone now through TheSocialMedwork.

Making an animated video for a startup on a limited budget

What makes a startup succeed?

With recent drops in new HIV diagnoses being linked to buying PrEP through online buyers clubs, the addition of PrEP to the WHO's essential medicine list, and the recent approval of generic PrEP in the US - here’s what you need to know.

What did we get up to, and what's next?

Get the latest news on MS research, the FDA approval of Ocrevus (ocrelizumab) for both relapsing and progressive forms of MS, insights and resources.

PTC Therapeutics announce the launch of Emflaza for the treatment of Duchenne muscular dystrophy (DMD) within the coming weeks, with an expected net price of $35,000.

What are the results from the clinical studies that led to the approval of edaravone, and how can patients access it in their country?

For the first time in 22 years, the US Food and Drug Administration (FDA) has approved a drug to treat patients with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease; a motor neuron disease characterised by muscular atrophy and weakness.

Top 5 medical breakthroughs from the past, present and future

The latest events surrounding the pricing of a Duchenne muscular dystrophy (DMD) treatment

Mirjam Bink’s story about her father and his attempt to access a new treatment for multiple system atrophy.

Last Thursday morning introduced us to spring, and what an entrance it made. The sun was shining, commuters passed each other with smiles, and the faint hum of summer could be heard for miles. 

The PBS, Australia’s national program responsible for providing subsidised prescriptions, has announced the addition of several new medicines

Australia’s personal importation scheme is a well-regulated system that has been around since the 1980s.

How our community celebrated remission!

As a patient, would you benefit from apps that alerted your support network every time you visited the hospital or had a few spare minutes to chat? Almost definitely, right?

Fighting an illness is rarely as simple as diagnosis-plus-medication-equals-improved-health.

We asked our community of patients what they recommend packing in a hospital bag, and the response was overwhelming.

Promising Results from Multiple Studies

The FDA approval of a promising new drug is offering new hope to multiple myeloma patients who have already been through various treatments. 

If you are experiencing ALS too, this page was written specifically for you.

Finance Management

Multiple myeloma is a treatable but incurable blood cancer that typically occurs in the bone marrow. 

When someone you love is battling illness, it’s natural to want to reach out and help in any way you can. Knowing how you can help isn’t always so clear.

A new treatment that targets a specific type of lung cancer has received FDA approval.